Oncotarget
The anti-tumor agent trabectedin has direct effects on tumor cells, blocking cell cycle and proliferation. See editorial by D’Incalci et al.
NRAS mutant melanoma – undrugable? |
https://doi.org/10.18632/oncotarget.970 Christian Posch, and Susana Ortiz-Urda |
494-495 |
PDF | HTML | How to cite | Order a Reprint |
New activities for the anti-tumor agent trabectedin: taking two birds with one stone |
https://doi.org/10.18632/oncotarget.968 Maurizio D’Incalci, Roberta Frapolli, Giovanni Germano, and Paola Allavena |
496-497 |
PDF | HTML | How to cite | Order a Reprint |
Regulation of mechanical stress by mammary epithelial tissue structure controls breast cancer cell invasion |
https://doi.org/10.18632/oncotarget.979 Derek C Radisky, and Celeste M Nelson |
498-499 |
PDF | HTML | How to cite | Order a Reprint |
Jak2V617F myeloproliferative neoplasm stem cells and interferon-alpha. |
https://doi.org/10.18632/oncotarget.986 Steven W Lane, and Ann Mullally |
500-501 |
PDF | HTML | How to cite | Order a Reprint |
A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care. |
https://doi.org/10.18632/oncotarget.969 Richard E. Kast, John A. Boockvar, Ansgar Brüning, Francesco Cappello, Wen-Wei Chang, Boris Cvek, Q Ping Dou, Alfonso Duenas-Gonzalez, Thomas Efferth, Daniele Focosi, Seyed H. Ghaffari, Georg Karpel-Massler, Kirsi Ketola, Alireza Khoshnevisan, Daniel Keizman, Nicolas Magné, Christine Marosi, Kerrie McDonald, Miguel Muñoz, Ameya Paranjpe, Mohammad H. Pourgholami, Iacopo Sardi, Avishay Sella, Kalkunte S. Srivenugopal, Marco Tuccori, Weiguang Wang, Christian R. Wirtz, and Marc-Eric Halatsch |
502-530 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Effects of CT-Xp Gene Knock down in Melanoma Cell Lines |
https://doi.org/10.18632/oncotarget.921 Otavia Luisa Caballero, Tzeela Cohen, Sita Gurung, Ramon Chua, Peishan Lee, Yao-Tseng Chen, Parmjit Jat, Lloyd J. Old, and Andrew J. G. Simpson |
531-541 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Galectin-3: a possible complementary marker to the PSA blood test |
https://doi.org/10.18632/oncotarget.923 Vitaly Balan, Yi Wang, Pratima Nangia-Makker, Dhonghyo Kho, Madhuri Bajaj, Daryn Smith, Lance Heilbrun, Avraham Raz, and Elisabeth Heath |
542-549 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Up-regulates Interleukin-6 in Cancer Cells and Induces Subsequent Development of Interstitial Pneumonia |
https://doi.org/10.18632/oncotarget.939 Yukari Ishiguro, Hitoshi Ishiguro, and Hiroshi Miyamoto |
550-559 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2α′: implications for pathological roles of CK2 in promoting cancer cell survival. |
https://doi.org/10.18632/oncotarget.948 Jacob P Turowec, Greg Vilk, Michelle Gabriel, and David W Litchfield |
560-571 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Exomic Sequencing of Four Rare Central Nervous System Tumor Types |
https://doi.org/10.18632/oncotarget.964 Chetan Bettegowda, Nishant Agrawal, Yuchen Jiao, Yuxuan Wang, Laura D. Wood, Fausto J. Rodriguez, Ralph H. Hruban, Gary L. Gallia, Zev A. Binder, Callen J. Riggins, Vafi Salmasi, Gregory J. Riggins, Zachary J. Reitman, Ahmed Rasheed, Stephen Keir, Sueli Shinjo, Suely Marie, Roger McLendon, George Jallo, Bert Vogelstein, Darrell Bigner, Hai Yan, Kenneth W. Kinzler, and Nickolas Papadopoulos |
572-583 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600EBRAF oncogene |
https://doi.org/10.18632/oncotarget.965 Arnaldur Hall, Kathrine Damm Meyle, Marina Krarup Lange, Martin Klima, May Sanderhoff, Christina Dahl, Cecilie Abildgaard, Katrine Thorup, Seyed Moein Moghimi, Per Bo Jensen, Jiri Bartek, Per Guldberg, and Claus Christensen |
584-599 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group |
https://doi.org/10.18632/oncotarget.918 Ketan Badani, Darby J.S. Thompson, Christine Buerki, Elai Davicioni, Jill Garrison, Mercedeh Ghadessi, Anirban P. Mitra, Penelope J. Wood, and John Hornberger |
600-609 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer |
https://doi.org/10.18632/oncotarget.934 Alka Mukhopadhyay, Thaer Khoury, Leighton Stein, Protul Shrikant, and Ashwani K. Sood |
610-621 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanisms |
https://doi.org/10.18632/oncotarget.938 Mark J Axelrod, Vicki Gordon, Mark Conaway, Adel Tarcsafalvi, Daniel J Neitzke, Daniel Gioeli, and Michael J Weber |
622-635 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Expression of Cancer/Testis Antigens is Correlated with Improved Survival in Glioblastoma |
https://doi.org/10.18632/oncotarget.950 Marcelo R.P. Freitas, Suzana M.F. Malheiros, João N. Stávale, Thaís P. Biassi, Fernando T. Zamunér, Maria D.F.S. Begnami, Fernado A. Soares, and André L. Vettore |
636-646 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC